Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience

Table 2 Genotype and allele frequencies of eNOS variants between patients and controls

eNOS G894T	Patients	Controls	OR Exp (B)	95% CI	p
eNOS G894T	n = 60 (%)	n = 60 (%)	OR Exp (B)	95% CI	p
Genotypes
GG	4 (6.7)	1 (1.7)	0.227*	0.023–2.207*	0.201*
GT	20 (33.3)	21 (35)	0.977*	0.453–2.111*	0.954*
TT	36 (60)	38 (63.3)	0.883^&	0.421–1.850^&	0.851^&
Alleles
G	28 (23.3)	23 (19.2)
T	92 (76.7)	97 (80.8)	1.000^&	0.550–1.819^&	1.000^&
eNOS VNTR
BB	40 (66.7)	42 (70)	0.881^&	0.406–1.913^&	0.844^&
BA	19 (31.6)	15 (25)	0.756*	0.338–1.692*	0.496*
AA	1 (1.7)	3 (5)	3.091*	0.299–31.981*	0.344*
Alleles
B	99 (82.5)	99 (82.5)	1.000^&	0.514–1.946^&	1.000^&
A	21 (17.5)	21 (17.5)	1.000^&	0.514–1.946^&	1.000^&

ISSN: 1472-6831